Cancer research
Pazopanib, an oral multi-targeted tyrosine kinase inhibitor, has shown promise in treating various cancers, including renal cell carcinoma, breast, and lung cancer. Researchers at the University States have conducted phase I and II clinical trials, demonstrating pazopanib's efficacy and safety profile. The medication targets key proteins responsible for
Cancer
Researchers at the University of Tokyo have made a groundbreaking discovery in the field of pancreatic cancer research. They identified a novel gene, C2orf18, also known as ANT2-binding protein (ANT2BP), as a crucial molecule involved in the development of pancreatic ductal adenocarcinoma (PDAC). This type of cancer has one of
Cancer
According to a study published in Cancer Science, cell-free plasma DNA levels in cancer patients show dynamic changes associated with the progression of radiation therapy. The researchers found that these nucleic acids have potential as new tumor markers. The study investigated plasma DNA concentrations in patients with cancer during radiation
Cancer research
Scientists at Case Western Reserve University have discovered that a small molecule called 9-aminoacridine (9AA) and its derivative, quinacrine, can selectively kill cancer cells by targeting key signaling pathways. The researchers found that 9AA treatment results in the downregulation of a specific catalytic subunit of the phosphoinositide 3-kinase (PI3K) family,
Cancer research
Researchers in Nanjing, China, have made significant progress in developing a potential new treatment for gastric cancer. The study, published in Cancer Biotherapy and Radiopharmaceuticals, used small interfering RNA (siRNA) to target the survivin gene, which is overexpressed in many types of human tumors, including gastric cancer. The results showed
Cancer research
Researchers at Scripps Research Institute have made new findings in cancer gene therapy, publishing a study in the journal Lung Cancer that challenges the role of UBE1L (UBA7) as a tumor suppressor gene in lung cancer development. According to the study, UBE1L deficiency did not accelerate lung cancer development in
Cancer
Gene therapy has shown promising results in tackling lung cancer, but its systemic delivery can be impaired by various factors. Scientists in Galway, Ireland, have made a breakthrough by utilizing mesenchymal stem cells (MSCs) to carry a tumouricidal gene therapy vector, which can home to tumour sites and induce apoptosis
Cancer
Researchers in Edmonton, Canada have discovered that autotaxin (ATX) can protect cancer cells from the apoptotic effects of Taxol, a commonly used chemotherapeutic agent in breast cancer treatment. The study, published in Oncogene, found that ATX converts extracellular lysophosphatidylcholine (LPC) into lysophosphatidate (LPA), which has been reported to affect cell
Cancer research
Recent research in the United States has made significant strides in understanding brain tumors, specifically gliomas, by developing spontaneous mouse models that more accurately reflect human disease and predict clinical efficacy. Scientists at the University of Minnesota created genetically engineered brain tumors in mice using plasmid DNA, inducing the disease
Drugs
Researchers at the University Hospital in Netherlands have reported a case of trastuzumab-induced pneumonitis in a female patient with HER2-positive metastatic breast cancer. The patient developed pulmonary infiltrates and pleural effusion dyspnea after several months of trastuzumab treatment, despite having been treated without complications with a combination of docetaxel, trastuzumab,
Cancer research
In a study published in Oncology Reports, researchers from Shandong University, Jinan, People's Republic of China, have found that estrogen and antiestrogens, such as tamoxifen and raloxifene, can regulate the growth of endometrial carcinoma cells by stimulating vascular endothelial growth factor (VEGF) production through estrogen-responsive finger protein (Efp)
Drugs
Researchers in Xian, People's Republic of China, have discovered that eukaryotic initiation factor eIF4E plays a crucial role in the malignant transformation, progression, and chemoresistance of human breast carcinoma. The overexpression of this gene has been found in various human malignancies, including breast carcinoma. A study published in
